Effects of Definitive Chemoradiotherapy on Respiratory Function Tests and Quality of Life Scores During Treatment of Lung Cancer

Duman, Evrim; Yildirim, Mustafa; Kaya, Vildan; Ozturk, Duriye; Inal, Aysun; Akarsu, Zeynep; Gunduz, Seyda; Yildiz, Mustafa

추천

검색

자료유형: 학술저널

저자정보: Duman, Evrim (Department of Radiation Oncology, Antalya Education and Research Hospital) Yildirim, Mustafa (Ministry of Health Batman Regional Goverment Hospital, Department of Medical Oncology) Kaya, Vildan (Suleyman Demirel University, Department of Radiation Oncology) Ozturk, Duriye (Department of Radiation Oncology, Afyon Kocatepe University) Inal, Aysun (Department of Radiation Oncology, Antalya Education and Research Hospital) Akarsu, Zeynep (Department of Radiation Oncology, Antalya Education and Research Hospital) Gunduz, Seyda (Department of Medical Oncology, Antalya Education and Research Hospital) Yildiz, Mustafa (Department of Medical Oncology, Antalya Education and Research Hospital)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제16권 제15호

발행연도: 2015.1

수록면: 6,779 - 6,782 (4page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Chemoradiotherapy is an important treatment modality for lung cancers. The aim of this study was to investigate alterations in, as well as the interrelationship between, lung function and quality of life of patients receiving chemoradiotherapy due to locally advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) limited to the thorax. Materials and Methods: The study included patients receiving definitive chemoradiotherapy for lung carcinoma. The respiratory function of the patients was assessed by measuring forced expiratory volume in 1 s per unit (FEV1) and forced expiratory volume in 1s per unit of vital capacity (FEV1/VC) before, in the middle of and after treatment. During the study, EORTC QLQ C30 and LC13 questionnaires developed by the Committee of the European Organization for Research and Treatment of Cancer (EORTC) were employed to evaluate the quality of life on the same day as respiratory function tests (RFT). Findings: The study included 23 patients in total: 19 (82.6%) diagnosed with NSCLC and 4 (17.4%) with SCLC. The average percentage FEV1 was $55.6{\pm}21.8%$ in the pre-treatment period, $56.2{\pm}19.2%$ in the middle of treatment and $60.4{\pm}22%$ at the end of treatment. The improvement in functional scores, symptom scores and general health scores during treatment was not statistically significant (P= 0.568, P= 0.734, P= 0.680, P=0.757 respectively). Conclusions: Although this study showed an improvement in respiratory function and quality of life of patients during treatment with thoracic chemoradiotherapy, no statistically significant results were obtained. While evaluating the effectiveness of treatments for lung carcinoma, the effects of treatment on respiratory function and quality of life should be considered.

#Lung carcinoma #chemoradiotherapy #respiratory function #quality of life

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!